Bausch Health Cos Debt to Equity Ratio 2010-2023 | BHC
Current and historical debt to equity ratio values for Bausch Health Cos (BHC) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Bausch Health Cos debt/equity for the three months ending December 31, 2023 was 0.00.
| Bausch Health Cos Debt/Equity Ratio Historical Data |
| Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
| 2023-12-31 |
$27.43B |
$-0.08B |
-334.54 |
| 2023-09-30 |
$27.30B |
$-0.24B |
-116.17 |
| 2023-06-30 |
$25.23B |
$0.27B |
93.11 |
| 2023-03-31 |
$25.30B |
$0.15B |
174.48 |
| 2022-12-31 |
$25.43B |
$0.26B |
97.79 |
| 2022-09-30 |
$25.87B |
$0.43B |
59.73 |
| 2022-06-30 |
$27.92B |
$0.25B |
110.35 |
| 2022-03-31 |
$29.23B |
$-0.14B |
-207.31 |
| 2021-12-31 |
$29.24B |
$-0.03B |
-859.88 |
| 2021-09-30 |
$29.39B |
$-0.14B |
-217.68 |
| 2021-06-30 |
$30.65B |
$-0.61B |
-50.17 |
| 2021-03-31 |
$30.32B |
$-0.12B |
-244.52 |
| 2020-12-31 |
$30.59B |
$0.61B |
50.57 |
| 2020-09-30 |
$30.91B |
$0.66B |
47.19 |
| 2020-06-30 |
$30.85B |
$0.55B |
56.50 |
| 2020-03-31 |
$31.08B |
$0.79B |
39.34 |
| 2019-12-31 |
$32.73B |
$1.14B |
28.81 |
| 2019-09-30 |
$29.11B |
$2.56B |
11.37 |
| 2019-06-30 |
$29.67B |
$2.69B |
11.04 |
| 2019-03-31 |
$29.77B |
$2.78B |
10.71 |
| 2018-12-31 |
$29.68B |
$2.82B |
10.54 |
| 2018-09-30 |
$30.54B |
$3.24B |
9.44 |
| 2018-06-30 |
$30.89B |
$3.56B |
8.68 |
| 2018-03-31 |
$31.28B |
$4.52B |
6.92 |
| 2017-12-31 |
$31.55B |
$5.94B |
5.31 |
| 2017-09-30 |
$34.55B |
$5.42B |
6.37 |
| 2017-06-30 |
$37.70B |
$4.03B |
9.36 |
| 2017-03-31 |
$38.34B |
$3.99B |
9.60 |
| 2016-12-31 |
$40.27B |
$3.26B |
12.36 |
| 2016-09-30 |
$41.49B |
$4.27B |
9.71 |
| 2016-06-30 |
$42.26B |
$5.40B |
7.82 |
| 2016-03-31 |
$43.24B |
$5.78B |
7.49 |
| 2015-12-31 |
$42.94B |
$6.03B |
7.12 |
| 2015-09-30 |
$41.99B |
$6.47B |
6.50 |
| 2015-06-30 |
$41.79B |
$6.56B |
6.37 |
| 2015-03-31 |
$31.99B |
$6.58B |
4.87 |
| 2014-12-31 |
$20.90B |
$5.40B |
3.87 |
| 2014-09-30 |
$21.83B |
$5.23B |
4.17 |
| 2014-06-30 |
$22.53B |
$5.37B |
4.20 |
| 2014-03-31 |
$22.79B |
$5.20B |
4.38 |
| 2013-12-31 |
$22.74B |
$5.23B |
4.35 |
| 2013-09-30 |
$23.14B |
$5.06B |
4.57 |
| 2013-06-30 |
$14.08B |
$5.70B |
2.47 |
| 2013-03-31 |
$13.90B |
$3.59B |
3.88 |
| 2012-12-31 |
$14.23B |
$3.72B |
3.83 |
| 2012-09-30 |
$10.36B |
$3.79B |
2.74 |
| 2012-06-30 |
$10.32B |
$3.70B |
2.79 |
| 2012-03-31 |
$9.54B |
$4.08B |
2.34 |
| 2011-12-31 |
$9.18B |
$3.93B |
2.34 |
| 2011-09-30 |
$7.80B |
$4.01B |
1.94 |
| 2011-06-30 |
$7.16B |
$4.67B |
1.54 |
| 2011-03-31 |
$6.98B |
$4.71B |
1.48 |
| 2010-12-31 |
$5.88B |
$4.91B |
1.20 |
| 2010-09-30 |
$5.79B |
$5.35B |
1.08 |
| 2010-06-30 |
$0.67B |
$1.36B |
0.49 |
| 2010-03-31 |
$0.66B |
$1.34B |
0.49 |
| 2009-12-31 |
$0.71B |
$1.35B |
0.52 |
| 2009-09-30 |
$0.73B |
$1.29B |
0.57 |
| 2009-06-30 |
$0.80B |
$1.25B |
0.64 |
| 2009-03-31 |
$0.38B |
$1.18B |
0.32 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$3.164B |
$8.757B |
|
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|
